Skip to main content
Erschienen in: International Urology and Nephrology 12/2017

27.09.2017 | Nephrology - Original Paper

Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage

verfasst von: Yanbei Sun, Lijuan Jiang, Xiaonan Shao

Erschienen in: International Urology and Nephrology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the predictive value of procalcitonin (PCT) in patients with stage 1–4 and stage 5 chronic kidney disease (CKD).

Methods

Five hundred and forty-one CKD inpatients were retrospectively analyzed and divided into CKD stage 1–4 (CKD1–4) and CKD stage 5 (CKD5) groups. Each group was further divided into non-infection, local infection, and sepsis subgroups. The clinical characteristics and inflammatory indexes of each subgroup including PCT, C-reactive protein (CRP), white blood cell count (WBC), and neutrophil percentage (N%) were compared, and the receiver operating characteristic curves to predict local infection and sepsis were plotted.

Results

Our research showed that the incidence and severity of infection in CKD5 group were significantly higher than those of CKD1–4 group; the baseline PCT level in CKD patients increased as renal function decreased and strongly correlated with CKD staging (r = 0.749); for CKD1–4 group, PCT, WBC, and N% could predict sepsis with the area under the curve (AUC) of 0.956, 0.854, and 0.917, respectively, but only CRP could predict local infection with AUC of 0.729, and for CKD5 group, only PCT and CRP could predict local infection with AUC of 0.715 and 0.780, respectively, and only PCT and N% could predict sepsis with AUC of 0.823 and 0.683, respectively.

Conclusions

The baseline PCT level of CKD patients is negatively correlated with renal function. In both CKD1–4 and CKD5 patients, the predictive value of PCT for local infection is not as good as that of CRP, while it has a significant advantage in predicting sepsis.
Literatur
1.
Zurück zum Zitat Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88:950–957CrossRefPubMedPubMedCentral Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88:950–957CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int 59:S206–S211CrossRef Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int 59:S206–S211CrossRef
3.
Zurück zum Zitat McDonald HI, Thomas SL, Nitsch D (2014) Chronic kidney disease as a risk factor for acute community-acquired infections in high-income countries: a systematic review. BMJ Open 4:e004100CrossRefPubMedPubMedCentral McDonald HI, Thomas SL, Nitsch D (2014) Chronic kidney disease as a risk factor for acute community-acquired infections in high-income countries: a systematic review. BMJ Open 4:e004100CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR (2009) CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 54:24–32CrossRefPubMed James MT, Quan H, Tonelli M, Manns BJ, Faris P, Laupland KB, Hemmelgarn BR (2009) CKD and risk of hospitalization and death with pneumonia. Am J Kidney Dis 54:24–32CrossRefPubMed
5.
Zurück zum Zitat Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2012) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 59:356–363CrossRefPubMed Dalrymple LS, Katz R, Kestenbaum B, de Boer IH, Fried L, Sarnak MJ, Shlipak MG (2012) The risk of infection-related hospitalization with decreased kidney function. Am J Kidney Dis 59:356–363CrossRefPubMed
8.
Zurück zum Zitat Herget-Rosenthal S, Marggraf G, Pietruck F, Husing J, Strupat M, Philipp T, Kribben A (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16:975–979CrossRefPubMed Herget-Rosenthal S, Marggraf G, Pietruck F, Husing J, Strupat M, Philipp T, Kribben A (2001) Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant 16:975–979CrossRefPubMed
9.
Zurück zum Zitat Sitter T, Schmidt M, Schneider S, Schiffl H (2002) Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 15:297–301PubMed Sitter T, Schmidt M, Schneider S, Schiffl H (2002) Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin. J Nephrol 15:297–301PubMed
10.
Zurück zum Zitat Dahaba AA, Rehak PH, List WF (2003) Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 29:579–583CrossRefPubMed Dahaba AA, Rehak PH, List WF (2003) Procalcitonin and C-reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med 29:579–583CrossRefPubMed
11.
Zurück zum Zitat Dumea R, Siriopol D, Hogas S, Mititiuc I, Covic A (2014) Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients. Int Urol Nephrol 46:461–468CrossRefPubMed Dumea R, Siriopol D, Hogas S, Mititiuc I, Covic A (2014) Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients. Int Urol Nephrol 46:461–468CrossRefPubMed
12.
Zurück zum Zitat Grace E, Turner RM (2014) Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis 59:1761–1767CrossRefPubMed Grace E, Turner RM (2014) Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy. Clin Infect Dis 59:1761–1767CrossRefPubMed
13.
Zurück zum Zitat Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H (2000) Procalcitonin in patients undergoing chronic hemodialysis. Nephron 84:187–188CrossRefPubMed Schmidt M, Burchardi C, Sitter T, Held E, Schiffl H (2000) Procalcitonin in patients undergoing chronic hemodialysis. Nephron 84:187–188CrossRefPubMed
14.
Zurück zum Zitat Meisner M, Schmidt J, Huttner H, Tschaikowsky K (2000) The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 26(Suppl 2):S212–S216CrossRefPubMed Meisner M, Schmidt J, Huttner H, Tschaikowsky K (2000) The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 26(Suppl 2):S212–S216CrossRefPubMed
15.
Zurück zum Zitat Opatrna S, Klaboch J, Opatrny K Jr, Holubec L, Tomsu M, Sefrna F, Topolcan O (2005) Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 25:470–472PubMed Opatrna S, Klaboch J, Opatrny K Jr, Holubec L, Tomsu M, Sefrna F, Topolcan O (2005) Procalcitonin levels in peritoneal dialysis patients. Perit Dial Int 25:470–472PubMed
16.
Zurück zum Zitat Herget-Rosenthal S, Klein T, Marggraf G, Hirsch T, Jakob HG, Philipp T, Kribben A (2005) Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 61:180–186CrossRefPubMed Herget-Rosenthal S, Klein T, Marggraf G, Hirsch T, Jakob HG, Philipp T, Kribben A (2005) Modulation and source of procalcitonin in reduced renal function and renal replacement therapy. Scand J Immunol 61:180–186CrossRefPubMed
17.
Zurück zum Zitat Steinbach G, Bolke E, Grunert A, Storck M, Orth K (2004) Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 116:849–853CrossRefPubMed Steinbach G, Bolke E, Grunert A, Storck M, Orth K (2004) Procalcitonin in patients with acute and chronic renal insufficiency. Wien Klin Wochenschr 116:849–853CrossRefPubMed
18.
Zurück zum Zitat Yilmaz FM, Yilmaz G, Akay H, Duranay M, Yucel D (2007) Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 44:482–484CrossRefPubMed Yilmaz FM, Yilmaz G, Akay H, Duranay M, Yucel D (2007) Evaluation of a card test for procalcitonin in continuous ambulatory peritoneal dialysis peritonitis. Ann Clin Biochem 44:482–484CrossRefPubMed
19.
Zurück zum Zitat Guz G, Colak B, Hizel K, Reis KA, Erten Y, Bali M, Sindel S (2006) Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 26:240–248PubMed Guz G, Colak B, Hizel K, Reis KA, Erten Y, Bali M, Sindel S (2006) Procalcitonin and conventional markers of inflammation in peritoneal dialysis patients and peritonitis. Perit Dial Int 26:240–248PubMed
20.
Zurück zum Zitat Lam MF, Leung JC, Lam CW, Tse KC, Lo WK, Lui SL, Chan TM, Tam S, Lai KN (2008) Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 28:377–384PubMed Lam MF, Leung JC, Lam CW, Tse KC, Lo WK, Lui SL, Chan TM, Tam S, Lai KN (2008) Procalcitonin fails to differentiate inflammatory status or predict long-term outcomes in peritoneal dialysis-associated peritonitis. Perit Dial Int 28:377–384PubMed
21.
Zurück zum Zitat Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, Riou B, Bernard M, Hausfater P (2008) Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 36:1147–1154CrossRefPubMed Amour J, Birenbaum A, Langeron O, Le Manach Y, Bertrand M, Coriat P, Riou B, Bernard M, Hausfater P (2008) Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 36:1147–1154CrossRefPubMed
22.
Zurück zum Zitat Foundation NK (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266 Foundation NK (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266
23.
Zurück zum Zitat Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580–637CrossRefPubMed Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580–637CrossRefPubMed
24.
Zurück zum Zitat Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754CrossRefPubMed Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N, File T, Fine MJ, Gross PA, Martinez F, Marrie TJ, Plouffe JF, Ramirez J, Sarosi GA, Torres A, Wilson R, Yu VL (2001) Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754CrossRefPubMed
26.
Zurück zum Zitat Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120CrossRefPubMed Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120CrossRefPubMed
27.
Zurück zum Zitat Farthing M, Salam MA, Lindberg G, Dite P, Khalif I, Salazar-Lindo E, Ramakrishna BS, Goh KL, Thomson A, Khan AG, Krabshuis J, LeMair A (2013) Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol 47:12–20CrossRefPubMed Farthing M, Salam MA, Lindberg G, Dite P, Khalif I, Salazar-Lindo E, Ramakrishna BS, Goh KL, Thomson A, Khan AG, Krabshuis J, LeMair A (2013) Acute diarrhea in adults and children: a global perspective. J Clin Gastroenterol 47:12–20CrossRefPubMed
28.
Zurück zum Zitat Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423CrossRefPubMed Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG (2010) Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30:393–423CrossRefPubMed
29.
Zurück zum Zitat O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S (2011) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 39:S1–S34CrossRefPubMed O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S (2011) Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 39:S1–S34CrossRefPubMed
30.
Zurück zum Zitat Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW (2006) Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 333:1047CrossRefPubMedPubMedCentral Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW (2006) Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 333:1047CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR (2008) Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 168:2333–2339CrossRefPubMed James MT, Laupland KB, Tonelli M, Manns BJ, Culleton BF, Hemmelgarn BR (2008) Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 168:2333–2339CrossRefPubMed
32.
Zurück zum Zitat Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int 29:297–302PubMed Davenport A (2009) Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002–2003. Perit Dial Int 29:297–302PubMed
33.
Zurück zum Zitat Mactier R (2009) Peritonitis is still the achilles’ heel of peritoneal dialysis. Perit Dial Int 29:262–266PubMed Mactier R (2009) Peritonitis is still the achilles’ heel of peritoneal dialysis. Perit Dial Int 29:262–266PubMed
34.
Zurück zum Zitat Hildebrand A, Komenda P, Miller L, Rigatto C, Verrelli M, Sood AR, Sathianathan C, Reslerova M, Eng L, Eng A, Sood MM (2010) Peritonitis and exit site infections in First Nations patients on peritoneal dialysis. Clin J Am Soc Nephrol 5:1988–1995CrossRefPubMedPubMedCentral Hildebrand A, Komenda P, Miller L, Rigatto C, Verrelli M, Sood AR, Sathianathan C, Reslerova M, Eng L, Eng A, Sood MM (2010) Peritonitis and exit site infections in First Nations patients on peritoneal dialysis. Clin J Am Soc Nephrol 5:1988–1995CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovannini L, Palla R (2000) The link of biocompatibility to cytokine production. Kidney Int 76:S96–S103CrossRef Panichi V, Migliori M, De Pietro S, Taccola D, Andreini B, Metelli MR, Giovannini L, Palla R (2000) The link of biocompatibility to cytokine production. Kidney Int 76:S96–S103CrossRef
36.
Zurück zum Zitat Lai KN, Leung JC (2010) Inflammation in peritoneal dialysis. Nephron Clin Pract 116:c11–c18CrossRefPubMed Lai KN, Leung JC (2010) Inflammation in peritoneal dialysis. Nephron Clin Pract 116:c11–c18CrossRefPubMed
37.
Zurück zum Zitat Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217CrossRefPubMed Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J (2004) Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39:206–217CrossRefPubMed
38.
Zurück zum Zitat Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50:34–41CrossRefPubMed Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA (2007) Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 50:34–41CrossRefPubMed
39.
Zurück zum Zitat Tang H, Huang T, Jing J, Shen H, Cui W (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infect 37:497–507CrossRef Tang H, Huang T, Jing J, Shen H, Cui W (2009) Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infect 37:497–507CrossRef
40.
Zurück zum Zitat Meisner M, Huttemann E, Lohs T, Kasakov L, Reinhart K (2000) Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol 17:665–671CrossRefPubMed Meisner M, Huttemann E, Lohs T, Kasakov L, Reinhart K (2000) Elimination of procalcitonin and plasma concentrations during continuous veno-venous haemodiafiltration in septic patients. Eur J Anaesthesiol 17:665–671CrossRefPubMed
41.
Zurück zum Zitat Meisner M, Huttemann E, Lohs T, Kasakov L, Reinhart K (2001) Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 15:171–175CrossRefPubMed Meisner M, Huttemann E, Lohs T, Kasakov L, Reinhart K (2001) Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 15:171–175CrossRefPubMed
42.
Zurück zum Zitat Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18:79–87CrossRefPubMed Meisner M, Lohs T, Huettemann E, Schmidt J, Hueller M, Reinhart K (2001) The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol 18:79–87CrossRefPubMed
43.
Zurück zum Zitat Park JH, Kim DH, Jang HR, Kim MJ, Jung SH, Lee JE, Huh W, Kim YG, Kim DJ, Oh HY (2014) Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study. Crit Care 18:640CrossRefPubMedPubMedCentral Park JH, Kim DH, Jang HR, Kim MJ, Jung SH, Lee JE, Huh W, Kim YG, Kim DJ, Oh HY (2014) Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study. Crit Care 18:640CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Lavin-Gomez BA, Palomar-Fontanet R, Gago-Fraile M, Quintanar-Lartundo JA, Gomez-Palomo E, Gonzalez-Lamuno D, Garcia-Unzueta MT, Arias-Rodriguez MA, Gomez-Gerique JA (2011) Inflammation markers, chronic kidney disease, and renal replacement therapy. Adv Perit Dial 27:33–37PubMed Lavin-Gomez BA, Palomar-Fontanet R, Gago-Fraile M, Quintanar-Lartundo JA, Gomez-Palomo E, Gonzalez-Lamuno D, Garcia-Unzueta MT, Arias-Rodriguez MA, Gomez-Gerique JA (2011) Inflammation markers, chronic kidney disease, and renal replacement therapy. Adv Perit Dial 27:33–37PubMed
45.
Zurück zum Zitat Lorton F, Veinberg F, Ielsch D, Deschenes G, Bensman A, Ulinski T (2007) Procalcitonin serum levels in children undergoing chronic haemodialysis. Pediatr Nephrol 22:430–435CrossRefPubMed Lorton F, Veinberg F, Ielsch D, Deschenes G, Bensman A, Ulinski T (2007) Procalcitonin serum levels in children undergoing chronic haemodialysis. Pediatr Nephrol 22:430–435CrossRefPubMed
46.
Zurück zum Zitat Giovanella L (2012) Serum procalcitonin and calcitonin normal values before and after calcium gluconate infusion. Exp Clin Endocrinol Diabetes 120:169–170CrossRefPubMed Giovanella L (2012) Serum procalcitonin and calcitonin normal values before and after calcium gluconate infusion. Exp Clin Endocrinol Diabetes 120:169–170CrossRefPubMed
47.
Zurück zum Zitat Lee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC (2013) Diagnostic value of procalcitonin for bacterial infection in elderly patients—a systemic review and meta-analysis. Int J Clin Pract 67:1350–1357CrossRefPubMed Lee SH, Chan RC, Wu JY, Chen HW, Chang SS, Lee CC (2013) Diagnostic value of procalcitonin for bacterial infection in elderly patients—a systemic review and meta-analysis. Int J Clin Pract 67:1350–1357CrossRefPubMed
48.
Zurück zum Zitat El-Sayed D, Grotts J, Golgert WA, Sugar AM (2014) Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment. Open Forum Infect Dis 1:ofu068CrossRefPubMedPubMedCentral El-Sayed D, Grotts J, Golgert WA, Sugar AM (2014) Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment. Open Forum Infect Dis 1:ofu068CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8:R234–R242CrossRefPubMedPubMedCentral Castelli GP, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L (2004) Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 8:R234–R242CrossRefPubMedPubMedCentral
Metadaten
Titel
Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage
verfasst von
Yanbei Sun
Lijuan Jiang
Xiaonan Shao
Publikationsdatum
27.09.2017
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 12/2017
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-017-1710-z

Weitere Artikel der Ausgabe 12/2017

International Urology and Nephrology 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.